{"schema_version":"secwatch.filing_event.v1","accession":"0001555280-23-000166","form_type":"8-K","ticker":"ZTS","cik":"0001555280","company_name":"Zoetis Inc.","filed_at":"2023-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.371448+00:00","generated_at":"2026-06-14T14:30:02.861009+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Zoetis Investor Day targets mid-to-high single-digit revenue growth, $1B+ peak OA pain franchise","bullets":["Annual revenue growth target of mid-to-high single digits over next 3-5 years.","Osteoarthritis pain franchise expected to exceed $1B in peak sales.","Existing billion-dollar franchises in dermatology and pet parasiticides to be expanded.","Drive ROIC accretion and margin improvement through revenue growth and global scale leverage.","Disciplined capital allocation balancing investments and return of capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001555280-23-000166","json":"https://secwatch.observer/filing/0001555280-23-000166.json","markdown":"https://secwatch.observer/filing/0001555280-23-000166.md","text":"https://secwatch.observer/filing/0001555280-23-000166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555280/000155528023000166/0001555280-23-000166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555280/000155528023000166/zts-20230525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T14:30:02.861009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}